SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: lindao who wrote (54757)7/16/2000 9:16:54 PM
From: y2kfree_radical   of 150070
 
LINDAO-excellent discussion--CLYC is pharmacogenomics while QUINTILES is rational drug design--the former has the greatest explosive potential by increasing dramatically FDA approval rates of new drugs by identifying the few participants who would suffer major adverse reactions---even some older disapproved drugs which had great efficacy but bad outcomes in 5% of patient population could come back--also it will be paramount for drug firms to test their products this way to forestall the lawyers
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News